ArticleMolecular cancer therapeutics2025
Repurposing the DNA Labeling Agent EdU for Therapy against Heterogeneous Patient Glioblastoma.
Humeyra Kaanoglu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it